Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
10 hedge funds and large institutions have $78.6K invested in Bio-Path Holdings Inc in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 9 closing their positions.
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
47% less funds holding
Funds holding: 19 → 10 (-9)
72% less capital invested
Capital invested by funds: $277K → $78.6K (-$198K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$287 |
| 3 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$8 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$51.1K |
| 2 |
SA
Strategic Advocates
Logan,
Utah
|
-$16.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11.2K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8.2K |
| 5 |
HF
HRT Financial
New York
|
-$8K |
BPTH Hedge Fund Activity: Q1 2024 in Review
10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2024, worth a combined $78.6K — down 72% from $277K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BPTH and 0 opened new positions — a net loss of 9 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $10.9K. The largest seller was Geode Capital Management, exiting entirely with an estimated $51.1K sold.
- 10 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2024, down from 19 in Q4 2023.
- Funds reported $78.6K of Bio-Path Holdings Inc stock for Q1 2024, down 72% quarter-over-quarter.
- 0 funds opened new Bio-Path Holdings Inc positions in Q1 2024 and 9 closed out, a net change of -9 holders.
- The largest Bio-Path Holdings Inc buyer in Q1 2024 was Tower Research Capital (TRC), an estimated $10.9K added.
- The largest Bio-Path Holdings Inc seller in Q1 2024 was Geode Capital Management, an estimated $51.1K sold.
Based on aggregated 13F filings for Q1 2024.